Press release
Global Pancreatic Cancer Market is Projected to Surpass USD 7114.4 Million By the End of 2030 with a Growing CAGR of 12.5% | Infinium Global Research
To Know More Request a Sample of this Report: https://www.infiniumglobalresearch.com/market-reports/sample-request/1196
Market Insights: Forecasts and Growth Projections
The global pancreatic cancer market, valued at USD 2448.9 million in 2022, is projected to surge to USD 7114.4 million by 2030, exhibiting a robust Compound Annual Growth Rate (CAGR) of 12.5% during the forecast period from 2023 to 2030.
Pancreatic cancer, a severe and often fatal condition, originates in the pancreas-an abdominal organ situated behind the stomach. Its symptoms often remain unnoticed until the disease reaches advanced stages. Surgery, chemotherapy, radiation therapy, targeted therapy, and immunotherapy are among the available treatments. The market growth is propelled by the surge in pancreatic cancer cases globally and government initiatives aimed at enhancing healthcare infrastructure.
Driving Factors and Market Dynamics
The upsurge in pancreatic cancer incidence worldwide, largely linked to factors such as rising diabetes rates, obesity, and exposure to toxins, is a pivotal driver for market growth. The disease ranks among the leading causes of cancer-related deaths in various countries. Consequently, the demand for advanced diagnostic tools, effective treatment options, and supportive care services is witnessing a notable uptick. Technological advancements in diagnostics, including imaging techniques and biomarker testing, contribute to early and precise detection, thus improving patient outcomes. However, the high costs associated with treatments and their side effects pose challenges, potentially impeding market growth.
Regional Dynamics and Market Dominance
North America is poised to lead the pancreatic cancer market during the forecast period. The region's growth is underpinned by advanced medical facilities, innovative diagnostics, established competitors, and the rising prevalence of the ailment. Meanwhile, the Asia Pacific region exhibits significant potential for market expansion, driven by improving healthcare infrastructure and rising awareness.
Segments Covered
The report segments the global pancreatic cancer market based on type, treatment, diagnosis, route of administration, end-user, and distribution channel. These encompass exocrine and endocrine types, treatment modalities like chemotherapy, targeted therapy, immunotherapy, and more, various diagnosis methods, diverse administration routes, end-user categories including hospitals, specialty clinics, and homecare, as well as distribution channels such as hospital pharmacies, retail pharmacies, and online platforms.
Companies Profiled
The report offers comprehensive profiles of key industry players, including Bayer AG, Mylan (now part of Viatris), Teva Pharmaceutical Industries Ltd., Sanofi, Pfizer Inc., GSK plc, Novartis AG, Zydus Lifesciences Ltd., AstraZeneca, and Johnson & Johnson Services, Inc.
Enquire Here Get Customization & Check the Discount for the Report @ https://www.infiniumglobalresearch.com/market-reports/customization/1196
Table of Content
Chapter 1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
Chapter 2. Executive Summary
2.1. Pancreatic Cancer Market Highlights
2.2. Pancreatic Cancer Market Projection
2.3. Pancreatic Cancer Market Regional Highlights
Chapter 3. Global Pancreatic Cancer Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter`s Five Forces Analysis
3.4. IGR-Growth Matrix Analysis
3.4.1. IGR-Growth Matrix Analysis by Type
3.4.2. IGR-Growth Matrix Analysis by Treatment Type
3.4.3. IGR-Growth Matrix Analysis by Diagnosis
3.4.4. IGR-Growth Matrix Analysis by Route of Administration
3.4.5. IGR-Growth Matrix Analysis by End User
3.4.6. IGR-Growth Matrix Analysis by Distribution Channel
3.4.7. IGR-Growth Matrix Analysis by Region
3.5. Value Chain Analysis of Pancreatic Cancer Market
Chapter 4. Pancreatic Cancer Market Macro Indicator Analysis
Chapter 5. Company Profiles and Competitive Landscape
5.1. Competitive Landscape in the Global Pancreatic Cancer Market
5.2. Companies Profiles
5.2.1. Bayer AG
5.2.2. Mylan (is now part of Viatris)
5.2.3. Teva Pharmaceutical Industries Ltd.
5.2.4. Sanofi
5.2.5. Pfizer Inc.
5.2.6. GSK plc
5.2.7. Novartis AG
5.2.8. Zydus Lifesciences Ltd.
5.2.9. AstraZeneca
5.2.10. Johnson & Johnson Services, Inc.
Chapter 6. Global Pancreatic Cancer Market by Type
6.1. Exocrine
6.2. Endocrine
Chapter 7. Global Pancreatic Cancer Market by Treatment Type
7.1. Chemotherapy
7.2. Targeted Therapy
7.3. Immunotherapy
7.4. Hormone Therapy
7.5. Others
Chapter 8. Global Pancreatic Cancer Market by Diagnosis
8.1. Blood Test
8.2. Biopsy
8.3. Imaging Tests
8.4. Ultrasound
8.5. Computerized Tomography (CT) scans
8.6. Others
Chapter 9. Global Pancreatic Cancer Market by Route of Administration
9.1. Oral
9.2. Parenteral
9.3. Others
Chapter 10. Global Pancreatic Cancer Market by End User
10.1. Hospitals
10.2. Specialty Clinics
10.3. Homecare
10.4. Others
Chapter 11. Global Pancreatic Cancer Market by Distribution Channel
11.1. Hospital Pharmacy
11.2. Retail Pharmacy
11.3. Online Pharmacy
11.4. Others
Chapter 12. Global Pancreatic Cancer Market by Region 2023-2030
12.1. North America
12.1.1. North America Pancreatic Cancer Market by Type
12.1.2. North America Pancreatic Cancer Market by Treatment Type
12.1.3. North America Pancreatic Cancer Market by Diagnosis
12.1.4. North America Pancreatic Cancer Market by Route of Administration
12.1.5. North America Pancreatic Cancer Market by End User
12.1.6. North America Pancreatic Cancer Market by Distribution Channel
12.1.7. North America Pancreatic Cancer Market by Country
12.1.7.1. The U.S. Pancreatic Cancer Market
12.1.7.1.1. The U.S. Pancreatic Cancer Market by Type
12.1.7.1.2. The U.S. Pancreatic Cancer Market by Treatment Type
12.1.7.1.3. The U.S. Pancreatic Cancer Market by Diagnosis
12.1.7.1.4. The U.S. Pancreatic Cancer Market by Route of Administration
12.1.7.1.5. The U.S. Pancreatic Cancer Market by End User
12.1.7.1.6. The U.S. Pancreatic Cancer Market by Distribution Channel
12.1.7.2. Canada Pancreatic Cancer Market
12.1.7.2.1. Canada Pancreatic Cancer Market by Type
12.1.7.2.2. Canada Pancreatic Cancer Market by Treatment Type
12.1.7.2.3. Canada Pancreatic Cancer Market by Diagnosis
12.1.7.2.4. Canada Pancreatic Cancer Market by Route of Administration
12.1.7.2.5. Canada Pancreatic Cancer Market by End User
12.1.7.2.6. Canada Pancreatic Cancer Market by Distribution Channel
12.1.7.3. Mexico Pancreatic Cancer Market
12.1.7.3.1. Mexico Pancreatic Cancer Market by Type
12.1.7.3.2. Mexico Pancreatic Cancer Market by Treatment Type
12.1.7.3.3. Mexico Pancreatic Cancer Market by Diagnosis
12.1.7.3.4. Mexico Pancreatic Cancer Market by Route of Administration
12.1.7.3.5. Mexico Pancreatic Cancer Market by End User
12.1.7.3.6. Mexico Pancreatic Cancer Market by Distribution Channel
12.2. Europe
12.2.1. Europe Pancreatic Cancer Market by Type
12.2.2. Europe Pancreatic Cancer Market by Treatment Type
12.2.3. Europe Pancreatic Cancer Market by Diagnosis
12.2.4. Europe Pancreatic Cancer Market by Route of Administration
12.2.5. Europe Pancreatic Cancer Market by End User
12.2.6. Europe Pancreatic Cancer Market by Distribution Channel
12.2.7. Europe Pancreatic Cancer Market by Country
12.2.7.1. Germany Pancreatic Cancer Market
12.2.7.1.1. Germany Pancreatic Cancer Market by Type
12.2.7.1.2. Germany Pancreatic Cancer Market by Treatment Type
12.2.7.1.3. Germany Pancreatic Cancer Market by Diagnosis
12.2.7.1.4. Germany Pancreatic Cancer Market by Route of Administration
12.2.7.1.5. Germany Pancreatic Cancer Market by End User
12.2.7.1.6. Germany Pancreatic Cancer Market by Distribution Channel
12.2.7.2. United Kingdom Pancreatic Cancer Market
12.2.7.2.1. United Kingdom Pancreatic Cancer Market by Type
12.2.7.2.2. United Kingdom Pancreatic Cancer Market by Treatment Type
12.2.7.2.3. United Kingdom Pancreatic Cancer Market by Diagnosis
12.2.7.2.4. United Kingdom Pancreatic Cancer Market by Route of Administration
12.2.7.2.5. United Kingdom Pancreatic Cancer Market by End User
12.2.7.2.6. United Kingdom Pancreatic Cancer Market by Distribution Channel
12.2.7.3. France Pancreatic Cancer Market
12.2.7.3.1. France Pancreatic Cancer Market by Type
12.2.7.3.2. France Pancreatic Cancer Market by Treatment Type
12.2.7.3.3. France Pancreatic Cancer Market by Diagnosis
12.2.7.3.4. France Pancreatic Cancer Market by Route of Administration
12.2.7.3.5. France Pancreatic Cancer Market by End User
12.2.7.3.6. France Pancreatic Cancer Market by Distribution Channel
12.2.7.4. Italy Pancreatic Cancer Market
12.2.7.4.1. Italy Pancreatic Cancer Market by Type
12.2.7.4.2. Italy Pancreatic Cancer Market by Treatment Type
12.2.7.4.3. Italy Pancreatic Cancer Market by Diagnosis
12.2.7.4.4. Italy Pancreatic Cancer Market by Route of Administration
12.2.7.4.5. Italy Pancreatic Cancer Market by End User
12.2.7.4.6. Italy Pancreatic Cancer Market by Distribution Channel
12.2.7.5. Rest of Europe Pancreatic Cancer Market
12.2.7.5.1. Rest of Europe Pancreatic Cancer Market by Type
12.2.7.5.2. Rest of Europe Pancreatic Cancer Market by Treatment Type
12.2.7.5.3. Rest of Europe Pancreatic Cancer Market by Diagnosis
12.2.7.5.4. Rest of Europe Pancreatic Cancer Market by Route of Administration
12.2.7.5.5. Rest of Europe Pancreatic Cancer Market by End User
12.2.7.5.6. Rest of Europe Pancreatic Cancer Market by Distribution Channel
12.3. Asia Pacific
12.3.1. Asia Pacific Pancreatic Cancer Market by Type
12.3.2. Asia Pacific Pancreatic Cancer Market by Treatment Type
12.3.3. Asia Pacific Pancreatic Cancer Market by Diagnosis
12.3.4. Asia Pacific Pancreatic Cancer Market by Route of Administration
12.3.5. Asia Pacific Pancreatic Cancer Market by End User
12.3.6. Asia Pacific Pancreatic Cancer Market by Distribution Channel
12.3.7. Asia Pacific Pancreatic Cancer Market by Country
12.3.7.1. China Pancreatic Cancer Market
12.3.7.1.1. China Pancreatic Cancer Market by Type
12.3.7.1.2. China Pancreatic Cancer Market by Treatment Type
12.3.7.1.3. China Pancreatic Cancer Market by Diagnosis
12.3.7.1.4. China Pancreatic Cancer Market by Route of Administration
12.3.7.1.5. China Pancreatic Cancer Market by End User
12.3.7.1.6. China Pancreatic Cancer Market by Distribution Channel
12.3.7.2. Japan Pancreatic Cancer Market
12.3.7.2.1. Japan Pancreatic Cancer Market by Type
12.3.7.2.2. Japan Pancreatic Cancer Market by Treatment Type
12.3.7.2.3. Japan Pancreatic Cancer Market by Diagnosis
12.3.7.2.4. Japan Pancreatic Cancer Market by Route of Administration
12.3.7.2.5. Japan Pancreatic Cancer Market by End User
12.3.7.2.6. Japan Pancreatic Cancer Market by Distribution Channel
12.3.7.3. India Pancreatic Cancer Market
12.3.7.3.1. India Pancreatic Cancer Market by Type
12.3.7.3.2. India Pancreatic Cancer Market by Treatment Type
12.3.7.3.3. India Pancreatic Cancer Market by Diagnosis
12.3.7.3.4. India Pancreatic Cancer Market by Route of Administration
12.3.7.3.5. India Pancreatic Cancer Market by End User
12.3.7.3.6. India Pancreatic Cancer Market by Distribution Channel
12.3.7.4. South Korea Pancreatic Cancer Market
12.3.7.4.1. South Korea Pancreatic Cancer Market by Type
12.3.7.4.2. South Korea Pancreatic Cancer Market by Treatment Type
12.3.7.4.3. South Korea Pancreatic Cancer Market by Diagnosis
12.3.7.4.4. South Korea Pancreatic Cancer Market by Route of Administration
12.3.7.4.5. South Korea Pancreatic Cancer Market by End User
12.3.7.4.6. South Korea Pancreatic Cancer Market by Distribution Channel
12.3.7.5. Australia Pancreatic Cancer Market
12.3.7.5.1. Australia Pancreatic Cancer Market by Type
12.3.7.5.2. Australia Pancreatic Cancer Market by Treatment Type
12.3.7.5.3. Australia Pancreatic Cancer Market by Diagnosis
12.3.7.5.4. Australia Pancreatic Cancer Market by Route of Administration
12.3.7.5.5. Australia Pancreatic Cancer Market by End User
12.3.7.5.6. Australia Pancreatic Cancer Market by Distribution Channel
12.3.7.6. Rest of Asia-Pacific Pancreatic Cancer Market
12.3.7.6.1. Rest of Asia-Pacific Pancreatic Cancer Market by Type
12.3.7.6.2. Rest of Asia-Pacific Pancreatic Cancer Market by Treatment Type
12.3.7.6.3. Rest of Asia-Pacific Pancreatic Cancer Market by Diagnosis
12.3.7.6.4. Rest of Asia-Pacific Pancreatic Cancer Market by Route of Administration
12.3.7.6.5. Rest of Asia-Pacific Pancreatic Cancer Market by End User
12.3.7.6.6. Rest of Asia-Pacific Pancreatic Cancer Market by Distribution Channel
12.4. RoW
12.4.1. RoW Pancreatic Cancer Market by Type
12.4.2. RoW Pancreatic Cancer Market by Treatment Type
12.4.3. RoW Pancreatic Cancer Market by Diagnosis
12.4.4. RoW Pancreatic Cancer Market by Route of Administration
12.4.5. RoW Pancreatic Cancer Market by End User
12.4.6. RoW Pancreatic Cancer Market by Distribution Channel
12.4.7. RoW Pancreatic Cancer Market by Sub-region
12.4.7.1. Latin America Pancreatic Cancer Market
12.4.7.1.1. Latin America Pancreatic Cancer Market by Type
12.4.7.1.2. Latin America Pancreatic Cancer Market by Treatment Type
12.4.7.1.3. Latin America Pancreatic Cancer Market by Diagnosis
12.4.7.1.4. Latin America Pancreatic Cancer Market by Route of Administration
12.4.7.1.5. Latin America Pancreatic Cancer Market by End User
12.4.7.1.6. Latin America Pancreatic Cancer Market by Distribution Channel
12.4.7.2. Middle East Pancreatic Cancer Market
12.4.7.2.1. Middle East Pancreatic Cancer Market by Type
12.4.7.2.2. Middle East Pancreatic Cancer Market by Treatment Type
12.4.7.2.3. Middle East Pancreatic Cancer Market by Diagnosis
12.4.7.2.4. Middle East Pancreatic Cancer Market by Route of Administration
12.4.7.2.5. Middle East Pancreatic Cancer Market by End User
12.4.7.2.6. Middle East Pancreatic Cancer Market by Distribution Channel
12.4.7.3. Africa Pancreatic Cancer Market
12.4.7.3.1. Africa Pancreatic Cancer Market by Type
12.4.7.3.2. Africa Pancreatic Cancer Market by Treatment Type
12.4.7.3.3. Africa Pancreatic Cancer Market by Diagnosis
12.4.7.3.4. Africa Pancreatic Cancer Market by Route of Administration
12.4.7.3.5. Africa Pancreatic Cancer Market by End User
12.4.7.3.6. Africa Pancreatic Cancer Market by Distribution Channel
More Insights on this report, Speak to Our Analyst: https://www.infiniumglobalresearch.com/market-reports/enquiry/1196
Reasons to Buy this Report:
=> Comprehensive analysis of global as well as regional markets of Pancreatic Cancer.
=> Complete coverage of all the product types and application segments to analyze the trends, developments, and forecast of market size up to 2030.
=> Comprehensive analysis of the companies operating in this market. The company profile includes an analysis of the product portfolio, revenue, SWOT analysis, and the latest developments of the company.
=> Infinium Global Research- Growth Matrix presents an analysis of the product segments and geographies that market players should focus on to invest, consolidate, expand, and/or diversify.
2nd Floor, Ganadish Empire, Rahatani Chowk, Pimple Saudagar, Pimpri-Chinchwad, Maharashtra 411027
About Infinium Global Research:
Infinium Global Research is a business consulting and market research firm; a group of experts that caters to fulfilling business and market research needs of leading companies in various industry verticals and business segments. The company also serves government bodies, institutes, and non-profit/non-government organizations to meet their knowledge and information needs.
Through our information services and solutions, we assist our clients to improve their performance and assess the market conditions to achieve their organizational goals. Our team of experts and analysts are engaged in continuously monitoring and assessing the market conditions to provide knowledge support to our clients. To help our clients and to stay updated with the advances and inventions in technology, business processes, regulations, and the environment, Infinium often conducts regular meets with industry experts and opinion leaders. Our key opinion leaders are involved in monitoring and assessing the progress in the business environment, so as to offer the best opinion to our clients.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Pancreatic Cancer Market is Projected to Surpass USD 7114.4 Million By the End of 2030 with a Growing CAGR of 12.5% | Infinium Global Research here
News-ID: 3302441 • Views: …
More Releases from Infinium Global Research LLP
Infinium Global Research LLP Launches Comprehensive Service to Assist Foreign Co …
Pune, India - October 26, 2024 - Infinium Global Research LLP is excited to announce the launch of a dedicated service aimed at providing end-to-end support for foreign companies entering or expanding within the Indian market. With a strategic network of partnerships with top legal and consulting firms and increased presence across key Indian cities, Infinium is well-equipped to facilitate smooth market entry, operational setup, and business expansion for international…
Global Sterilization Services Market Size Worth USD 12.55 Billion By 2030 | CAGR …
Infinium Global Research, a leading provider of market intelligence, has recently launched an in-depth report on the Global Sterilization Services Market, offering comprehensive analysis and detailed insights into its segments and market trends.
The comprehensive study explores the impact of various factors such as drivers, restraints, and macro indicators on both the global and regional sterilization services market, providing crucial forecasts and dollar value projections.
To Know More Request a Sample of…
Global Proprotein Convertase Subtilisin/Kexin Type 9 Market is Projected to Surp …
Infinium Global Research introduces a detailed analysis of the global and regional Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) market, providing an extensive study of its segments, trends, forecasts, and dollar values in their latest report. This comprehensive study empowers stakeholders in the pharmaceutical and healthcare sectors with invaluable insights into this burgeoning market.
To Know More Request a Sample of this Report: https://www.infiniumglobalresearch.com/market-reports/sample-request/420
Market Insight:
The global Proprotein Convertase Subtilisin/Kexin Type 9 market,…
Global Neuromodulation Market is Anticipated to Reach USD 7.27 Billion and Growi …
Infinium Global Research, a pioneering market intelligence firm, introduces a comprehensive report delving into the Global Neuromodulation Market, providing extensive analysis and in-depth exploration of its segments, market trends, and projections.
To Know More Request a Sample of this Report: https://www.infiniumglobalresearch.com/market-reports/sample-request/93
Market Insight:
The global neuromodulation market, valued at USD 3.51 Billion in 2022, is poised to ascend to USD 7.27 Billion by 2030, exhibiting a noteworthy CAGR of 9.59% during the forecast…
More Releases for Pancreatic
Growing Pancreatic Cancer Cases : Pivotal Factor Influencing Pancreatic Cancer D …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Pancreatic Cancer Drugs Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for pancreatic cancer drugs has seen consistent growth over the past few years. An escalation from $3.96 billion in 2024 to $4.1 billion in 2025 is projected, marking a compound annual…
Pancreatic Cancer Diagnostic Market Surges In Response To Escalating Prevalence …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Pancreatic Cancer Diagnostic Market Through 2025?
The market size for pancreatic cancer diagnostics has been witnessing robust growth in recent times. There will be a growth from $4.24 billion in 2024 to $4.55 billion in 2025, showcasing a Compound Annual Growth Rate…
Pancreatic Cancer Diagnostic Market Surges In Response To Escalating Prevalence …
The Pancreatic Cancer Diagnostic Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Pancreatic Cancer Diagnostic Market Size and Projected Growth Rate?
There has been a significant expansion in the pancreatic cancer diagnostic market recently. This market is projected to increase from a value…
Pancreatic Amylase Reagent Kits: Streamlining Enzyme Analysis for Efficient Panc …
Pancreatic Amylase Reagent Kits Market 2023 Forecast: Unveiling Opportunities and Growth
Pancreatic Amylase Reagent Kits Market research report helps to recognize the market challenges and opportunities. Global Pancreatic Amylase Reagent Kits Market report contains the recent forecast research for the predicted period. The report extensively offers the latest information about the technological developments and market growth prospect on the basis of the regional landscape. This Report offers a complete evaluation of…
Pancreatic Cancer Therapy Market: Rise in Number of Patients Suffering with Panc …
Pancreatic cancer is one of the aggressive cancers that originate in the tissues of the pancreas and rapidly spreads to the nearby organs. Pancreatic cancer is the 12th most commonly occurring cancer in the world. According to the American Cancer Society, ~55,440 patients in the US are expected to be diagnosed with pancreatic cancer in 2018. Moreover, the ACS also reports that pancreatic cancer is the third leading cause of…
Pancreatic Cancer Treatment
Pancreatic Cancer Treatment Market describes its growth, size, share, Forecast and trends to 2025
Pancreatic Cancer Treatment Market Production and Demand Analysis 2019 to 2025
Pancreatic Cancer Treatment Market 2019 Manufacturing Analysis and Development Forecast 2025
Pancreatic Cancer Treatment Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025
Pancreatic Market to Insight By 2025: Top Key Vendors
Pancreatic cancer arises when cells in the pancreas, a glandular organ behind the stomach, begin to…
